Detailed Information

Cited 0 time in webofscience Cited 1 time in scopus
Metadata Downloads

Advances in MDS/AML and inositide signalling

Authors
De Stefano, AlessiaMarvi, Maria VittoriaFazio, AntoniettaMcCubrey, James ASuh, Pann-GhillRatti, StefanoRamazzotti, GiuliaManzoli, LuciaCocco, LucioFollo, Matilde Y
Issue Date
Jan-2023
Publisher
Elsevier Ltd
Keywords
Acute myeloid leukemia; Inositides; Myelodysplastic syndromes; PI3K/Akt/mTOR; Signalling
Citation
Advances in Biological Regulation, v.87
Journal Title
Advances in Biological Regulation
Volume
87
URI
http://scholarworks.bwise.kr/kbri/handle/2023.sw.kbri/980
DOI
10.1016/j.jbior.2023.100955
ISSN
2212-4926
Abstract
Aberrant signaling pathways regulating proliferation and differentiation of hematopoietic stem cells (HSCs) can contribute to disease pathogenesis and neoplastic growth. Phosphoinositides (PIs) are inositol phospholipids that are implicated in the regulation of critical signaling pathways: aberrant regulation of Phospholipase C (PLC) beta1, PLCgamma1 and the PI3K/Akt/mTOR pathway play essential roles in the pathogenesis of Myelodysplastic Syndromes (MDS) and Acute Myeloid Leukemia (AML).
Files in This Item
There are no files associated with this item.
Appears in
Collections
원장실 > 원장실 > 1. Journal Articles

qrcode

Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.

Altmetrics

Total Views & Downloads

BROWSE